This document proposes a pediatric-specific definition for acute respiratory distress syndrome (PARDS) based on a review of existing literature and datasets. Key aspects of the proposed definition include:
1) Simplifying chest imaging criteria to eliminate the need for bilateral infiltrates.
2) Using oxygenation index and oxygen saturation index instead of Pao2/Fio2 ratio to classify disease severity for invasively ventilated children.
3) Specifically including children with preexisting chronic lung disease or cyanotic congenital heart disease.
The proposed definition builds on the adult Berlin Definition but modifies some criteria to account for differences between pediatric and adult patients with ARDS. The goal is to improve the diagnosis and management
Obtaining Patient Information and Anxiety in Novice Nursing Students ,Article...jour644
Obtaining Patient Information and Anxiety in Novice Nursing Students , Obtaining Patient Information and Anxiety , During the First Clinical Rotation Journal of Comprehensive Nursing Research and Care ,Obtaining Patient Information and Anxiety, Obtaining Patient Information and Anxiety in Novice Nursing , Obtaining Patient Information , Anxiety in Novice Nursing Students ,
https://gexinonline.com/uploads/articles/article-jcnrc-143.pdf
Obtaining Patient Information and Anxiety in Novice Nursing Students , Obtaining Patient Information and Anxiety ,
During the First Clinical Rotation
Department of Nursing, Biola University, 13800 Biola Avenue, La Mirada, California 90639, USA
Journal of Comprehensive Nursing Research and Care
European Resuscitation Council Guidelines 2021: Paediatric Life SupportJavier González de Dios
The European Resuscitation Council (ERC) es el Consejo Interdisciplinario Europeo de Medicina de Reanimación y Atención Médica de Emergencia, que fue establecido en 1989 y cuyo objetivo es "preservar la vida humana poniendo a disposición de todos la reanimación cardiopulmonar de alta calidad".
Sus guías de práctica clínica (guidelines) son esperadas cada año con gran interés. Y acaban de aparecer las correspondientes al año 2021.
Pero los que más nos interesan como pediatras es el documento: European Resuscitation Council Guidelines 2021: Paediatric Life Support. Son 61 páginas de un documento que cabe leer y revisar con detenimiento para conocer los fundamentos actualizados de la reanimación cardiopulmonar pediátrica (de 0 a 18 años, exceptuando recién nacidos en el momento del parto). Pero en el cabe destacar los 5 mensajes clave de este nuevo documento y que vienen expuestos en esta tabla.
Obtaining Patient Information and Anxiety in Novice Nursing Students ,Article...jour644
Obtaining Patient Information and Anxiety in Novice Nursing Students , Obtaining Patient Information and Anxiety , During the First Clinical Rotation Journal of Comprehensive Nursing Research and Care ,Obtaining Patient Information and Anxiety, Obtaining Patient Information and Anxiety in Novice Nursing , Obtaining Patient Information , Anxiety in Novice Nursing Students ,
https://gexinonline.com/uploads/articles/article-jcnrc-143.pdf
Obtaining Patient Information and Anxiety in Novice Nursing Students , Obtaining Patient Information and Anxiety ,
During the First Clinical Rotation
Department of Nursing, Biola University, 13800 Biola Avenue, La Mirada, California 90639, USA
Journal of Comprehensive Nursing Research and Care
European Resuscitation Council Guidelines 2021: Paediatric Life SupportJavier González de Dios
The European Resuscitation Council (ERC) es el Consejo Interdisciplinario Europeo de Medicina de Reanimación y Atención Médica de Emergencia, que fue establecido en 1989 y cuyo objetivo es "preservar la vida humana poniendo a disposición de todos la reanimación cardiopulmonar de alta calidad".
Sus guías de práctica clínica (guidelines) son esperadas cada año con gran interés. Y acaban de aparecer las correspondientes al año 2021.
Pero los que más nos interesan como pediatras es el documento: European Resuscitation Council Guidelines 2021: Paediatric Life Support. Son 61 páginas de un documento que cabe leer y revisar con detenimiento para conocer los fundamentos actualizados de la reanimación cardiopulmonar pediátrica (de 0 a 18 años, exceptuando recién nacidos en el momento del parto). Pero en el cabe destacar los 5 mensajes clave de este nuevo documento y que vienen expuestos en esta tabla.
Inter grader agreement in the diabetic retinopathy screening program in pales...Riyad Banayot
This audit aims to assess the quality and accuracy of primary graders in the diabetic retinopathy screening program in the occupied Palestinian territories
The management of pediatric polytrauma -a simple reviewEmergency Live
This Clinical review, published by Libertas Academica, is an interesting commentary about the management of pediatric polytrauma.
This research was realized by
H. Mevius, M. van Dijk, A. Numanogluand A.B. van As between the MC-Sophia Childen's Hospital, Rotterdam, and the Red Cross War memorial Children's Hospital in Cape Town, South Africa.
H. Mevius1, M. van Dijk2–4, A. Numanoglu2,3 and A.B. van As2,3
1Medical Student, Department of Pediatric Surgery, Erasmus MC-Sophia Children’s Hospital, Rotterdam, The Netherlands. 2Department
of Paediatric Surgery, Red Cross War Memorial Children’s Hospital, Cape Town, South Africa. 3University of Cape Town, Cape Town,
South Africa. 4Department of Pediatric Surgery, Erasmus MC-Sophia Children’s Hospital, Rotterdam, The Netherlands.
1Medical Student, Department of Pediatric Surgery, Erasmus MC-Sophia Children’s Hospital, Rotterdam, The Netherlands. 2Department
of Paediatric Surgery, Red Cross War Memorial Children’s Hospital, Cape Town, South Africa. 3University of Cape Town, Cape Town,
South Africa. 4Department of Pediatric Surgery, Erasmus MC-Sophia Children’s Hospital, Rotterdam, The Netherlands.
ABSTRACT: Polytrauma is a major cause of mortality and morbidity in both developed and developing countries. The primary goal of this review is to provide a comprehensive overview on current knowledge in the management of pediatric polytrauma patients (PPPs). A database review was conducted based on a search in the Embase, Medline OVID-SP, Web of Science, Cochrane central, and Pubmed databases. Only studies with “paediatric population” and “polytrauma” as criteria were included. A total of 3310 citations were retrieved. Of these, 3271 were excluded after screening, based on title and abstract. The full texts of 39 articles were assessed; further selection left 25 articles to be included in this review. The most crucial point in the
management of PPPs is preparedness of the staff and an emergency room furnished with age-appropriate drugs and equipment combined with a systemic
approach.
KEY WORDS: pediatric population, polytrauma, multiple injuries, current management, review
Introduction
Polytrauma is a medical term that describes the condition of a patient subjected to multiple traumatic injuries and can be a life-threatening condition. These (life threatening) injuries typically affect two or more body regions and present a challenge for diagnosis and treatment.1,2 However, there is no consensus yet about the term polytrauma in both literature and practice.3
Polytrauma is a major cause of mortality and morbidity in both developed and developing countries. Despite its preventability, trauma remains the most common cause of death and disability in children.2 In fact, all over the world, more than 700,000 children under the age of 15 years die each year due to accidental injury.4 Leading causes of polytrauma are road traffic crashes, falls from heights, and
Kathryn Maitland describes the challenges faced with oxygen therapy as an emergency intervention in critical illness in African children.
Where Kathryn works, in East Africa, there is no access to intensive care. Caring for critically ill children is all done in the Emergency Department.
70% of the global burden of disease and deaths from pneumonia occurs in Southeast Asia and Sub-Saharan Africa. The WHO has published guidelines as to what classifies as pneumonia, severe pneumonia, and very severe pneumonia.
These classifications rely on clinical signs. However, Kathryn in her research has discovered that these classifications are rarely correlated with the actual underlying disease process.
Clinical signs are non-specific for the diagnosis of pneumonia. Oxygen is recommended for severe and very severe pneumonia.
This has led to calls to prioritise oxygen delivery in African hospitals. However, it has not led to change from a health department or funding viewpoint.
There are also oxygen delivery practicalities to consider. Often there is only one source of oxygen on a ward (if at all) with patients clustered around it.
The production of Oxygen may only happen in a few places.
Poor cylinder quality leads to leaks and therefore, low supply.
Concentrators are useful however they need regular servicing. They also rely on power, and in a region that experiences regular power outages, this can be problematic. When the power goes off, there is no oxygen available.
Kathryn asks – do all children actually need oxygen? There is still however a hidden burden of hypoxia.
Outside of Africa, Kathryn discusses the current state of equipoise on oxygen therapy.
Moreover, oxygen can be harmful if given inappropriately. This leads to concerns more broadly on the harms of oxygen therapy.
Kathryn concludes her talk by looking to the future. She discusses ongoing research and the implications for future practice in resource poor settings, and indeed the world.
Effects of moderate doses of vitamin A as an adjunct to the treatment of pneu...ISAMI1
Effects of moderate doses of vitamin A as an adjunct to the treatment of pneumonia in underweight and normal-weight children: a randomized, double-blind, placebo-controlled trial
CLINICAL PRACTICE GUIDELINEClinical Practice Guideline Th.docxclarebernice
CLINICAL PRACTICE GUIDELINE
Clinical Practice Guideline: The Diagnosis, Management,
and Prevention of Bronchiolitis
abstract
This guideline is a revision of the clinical practice guideline, “Diagnosis
and Management of Bronchiolitis,” published by the American Academy
of Pediatrics in 2006. The guideline applies to children from 1 through
23 months of age. Other exclusions are noted. Each key action state-
ment indicates level of evidence, benefit-harm relationship, and level
of recommendation. Key action statements are as follows: Pediatrics
2014;134:e1474–e1502
DIAGNOSIS
1a. Clinicians should diagnose bronchiolitis and assess disease se-
verity on the basis of history and physical examination (Evidence
Quality: B; Recommendation Strength: Strong Recommendation).
1b. Clinicians should assess risk factors for severe disease, such as
age less than 12 weeks, a history of prematurity, underlying car-
diopulmonary disease, or immunodeficiency, when making decisions
about evaluation and management of children with bronchiolitis
(Evidence Quality: B; Recommendation Strength: Moderate Rec-
ommendation).
1c. When clinicians diagnose bronchiolitis on the basis of history and
physical examination, radiographic or laboratory studies should
not be obtained routinely (Evidence Quality: B; Recommendation
Strength: Moderate Recommendation).
TREATMENT
2. Clinicians should not administer albuterol (or salbutamol) to in-
fants and children with a diagnosis of bronchiolitis (Evidence Qual-
ity: B; Recommendation Strength: Strong Recommendation).
3. Clinicians should not administer epinephrine to infants and children
with a diagnosis of bronchiolitis (Evidence Quality: B; Recommen-
dation Strength: Strong Recommendation).
4a. Nebulized hypertonic saline should not be administered to in-
fants with a diagnosis of bronchiolitis in the emergency depart-
ment (Evidence Quality: B; Recommendation Strength: Moderate
Recommendation).
4b. Clinicians may administer nebulized hypertonic saline to infants
and children hospitalized for bronchiolitis (Evidence Quality: B;
Recommendation Strength: Weak Recommendation [based on ran-
domized controlled trials with inconsistent findings]).
Shawn L. Ralston, MD, FAAP, Allan S. Lieberthal, MD, FAAP,
H. Cody Meissner, MD, FAAP, Brian K. Alverson, MD, FAAP, Jill E.
Baley, MD, FAAP, Anne M. Gadomski, MD, MPH, FAAP,
David W. Johnson, MD, FAAP, Michael J. Light, MD, FAAP,
Nizar F. Maraqa, MD, FAAP, Eneida A. Mendonca, MD, PhD,
FAAP, FACMI, Kieran J. Phelan, MD, MSc, Joseph J. Zorc, MD,
MSCE, FAAP, Danette Stanko-Lopp, MA, MPH, Mark A.
Brown, MD, Ian Nathanson, MD, FAAP, Elizabeth
Rosenblum, MD, Stephen Sayles III, MD, FACEP, and Sinsi
Hernandez-Cancio, JD
KEY WORDS
bronchiolitis, infants, children, respiratory syncytial virus,
evidence-based, guideline
ABBREVIATIONS
AAP—American Academy of Pediatrics
AOM—acute otitis media
CI—confidence interval
ED—emergency department
KAS—Key Action Statement
LOS—length of stay
MD—mean d ...
Inter grader agreement in the diabetic retinopathy screening program in pales...Riyad Banayot
This audit aims to assess the quality and accuracy of primary graders in the diabetic retinopathy screening program in the occupied Palestinian territories
The management of pediatric polytrauma -a simple reviewEmergency Live
This Clinical review, published by Libertas Academica, is an interesting commentary about the management of pediatric polytrauma.
This research was realized by
H. Mevius, M. van Dijk, A. Numanogluand A.B. van As between the MC-Sophia Childen's Hospital, Rotterdam, and the Red Cross War memorial Children's Hospital in Cape Town, South Africa.
H. Mevius1, M. van Dijk2–4, A. Numanoglu2,3 and A.B. van As2,3
1Medical Student, Department of Pediatric Surgery, Erasmus MC-Sophia Children’s Hospital, Rotterdam, The Netherlands. 2Department
of Paediatric Surgery, Red Cross War Memorial Children’s Hospital, Cape Town, South Africa. 3University of Cape Town, Cape Town,
South Africa. 4Department of Pediatric Surgery, Erasmus MC-Sophia Children’s Hospital, Rotterdam, The Netherlands.
1Medical Student, Department of Pediatric Surgery, Erasmus MC-Sophia Children’s Hospital, Rotterdam, The Netherlands. 2Department
of Paediatric Surgery, Red Cross War Memorial Children’s Hospital, Cape Town, South Africa. 3University of Cape Town, Cape Town,
South Africa. 4Department of Pediatric Surgery, Erasmus MC-Sophia Children’s Hospital, Rotterdam, The Netherlands.
ABSTRACT: Polytrauma is a major cause of mortality and morbidity in both developed and developing countries. The primary goal of this review is to provide a comprehensive overview on current knowledge in the management of pediatric polytrauma patients (PPPs). A database review was conducted based on a search in the Embase, Medline OVID-SP, Web of Science, Cochrane central, and Pubmed databases. Only studies with “paediatric population” and “polytrauma” as criteria were included. A total of 3310 citations were retrieved. Of these, 3271 were excluded after screening, based on title and abstract. The full texts of 39 articles were assessed; further selection left 25 articles to be included in this review. The most crucial point in the
management of PPPs is preparedness of the staff and an emergency room furnished with age-appropriate drugs and equipment combined with a systemic
approach.
KEY WORDS: pediatric population, polytrauma, multiple injuries, current management, review
Introduction
Polytrauma is a medical term that describes the condition of a patient subjected to multiple traumatic injuries and can be a life-threatening condition. These (life threatening) injuries typically affect two or more body regions and present a challenge for diagnosis and treatment.1,2 However, there is no consensus yet about the term polytrauma in both literature and practice.3
Polytrauma is a major cause of mortality and morbidity in both developed and developing countries. Despite its preventability, trauma remains the most common cause of death and disability in children.2 In fact, all over the world, more than 700,000 children under the age of 15 years die each year due to accidental injury.4 Leading causes of polytrauma are road traffic crashes, falls from heights, and
Kathryn Maitland describes the challenges faced with oxygen therapy as an emergency intervention in critical illness in African children.
Where Kathryn works, in East Africa, there is no access to intensive care. Caring for critically ill children is all done in the Emergency Department.
70% of the global burden of disease and deaths from pneumonia occurs in Southeast Asia and Sub-Saharan Africa. The WHO has published guidelines as to what classifies as pneumonia, severe pneumonia, and very severe pneumonia.
These classifications rely on clinical signs. However, Kathryn in her research has discovered that these classifications are rarely correlated with the actual underlying disease process.
Clinical signs are non-specific for the diagnosis of pneumonia. Oxygen is recommended for severe and very severe pneumonia.
This has led to calls to prioritise oxygen delivery in African hospitals. However, it has not led to change from a health department or funding viewpoint.
There are also oxygen delivery practicalities to consider. Often there is only one source of oxygen on a ward (if at all) with patients clustered around it.
The production of Oxygen may only happen in a few places.
Poor cylinder quality leads to leaks and therefore, low supply.
Concentrators are useful however they need regular servicing. They also rely on power, and in a region that experiences regular power outages, this can be problematic. When the power goes off, there is no oxygen available.
Kathryn asks – do all children actually need oxygen? There is still however a hidden burden of hypoxia.
Outside of Africa, Kathryn discusses the current state of equipoise on oxygen therapy.
Moreover, oxygen can be harmful if given inappropriately. This leads to concerns more broadly on the harms of oxygen therapy.
Kathryn concludes her talk by looking to the future. She discusses ongoing research and the implications for future practice in resource poor settings, and indeed the world.
Effects of moderate doses of vitamin A as an adjunct to the treatment of pneu...ISAMI1
Effects of moderate doses of vitamin A as an adjunct to the treatment of pneumonia in underweight and normal-weight children: a randomized, double-blind, placebo-controlled trial
CLINICAL PRACTICE GUIDELINEClinical Practice Guideline Th.docxclarebernice
CLINICAL PRACTICE GUIDELINE
Clinical Practice Guideline: The Diagnosis, Management,
and Prevention of Bronchiolitis
abstract
This guideline is a revision of the clinical practice guideline, “Diagnosis
and Management of Bronchiolitis,” published by the American Academy
of Pediatrics in 2006. The guideline applies to children from 1 through
23 months of age. Other exclusions are noted. Each key action state-
ment indicates level of evidence, benefit-harm relationship, and level
of recommendation. Key action statements are as follows: Pediatrics
2014;134:e1474–e1502
DIAGNOSIS
1a. Clinicians should diagnose bronchiolitis and assess disease se-
verity on the basis of history and physical examination (Evidence
Quality: B; Recommendation Strength: Strong Recommendation).
1b. Clinicians should assess risk factors for severe disease, such as
age less than 12 weeks, a history of prematurity, underlying car-
diopulmonary disease, or immunodeficiency, when making decisions
about evaluation and management of children with bronchiolitis
(Evidence Quality: B; Recommendation Strength: Moderate Rec-
ommendation).
1c. When clinicians diagnose bronchiolitis on the basis of history and
physical examination, radiographic or laboratory studies should
not be obtained routinely (Evidence Quality: B; Recommendation
Strength: Moderate Recommendation).
TREATMENT
2. Clinicians should not administer albuterol (or salbutamol) to in-
fants and children with a diagnosis of bronchiolitis (Evidence Qual-
ity: B; Recommendation Strength: Strong Recommendation).
3. Clinicians should not administer epinephrine to infants and children
with a diagnosis of bronchiolitis (Evidence Quality: B; Recommen-
dation Strength: Strong Recommendation).
4a. Nebulized hypertonic saline should not be administered to in-
fants with a diagnosis of bronchiolitis in the emergency depart-
ment (Evidence Quality: B; Recommendation Strength: Moderate
Recommendation).
4b. Clinicians may administer nebulized hypertonic saline to infants
and children hospitalized for bronchiolitis (Evidence Quality: B;
Recommendation Strength: Weak Recommendation [based on ran-
domized controlled trials with inconsistent findings]).
Shawn L. Ralston, MD, FAAP, Allan S. Lieberthal, MD, FAAP,
H. Cody Meissner, MD, FAAP, Brian K. Alverson, MD, FAAP, Jill E.
Baley, MD, FAAP, Anne M. Gadomski, MD, MPH, FAAP,
David W. Johnson, MD, FAAP, Michael J. Light, MD, FAAP,
Nizar F. Maraqa, MD, FAAP, Eneida A. Mendonca, MD, PhD,
FAAP, FACMI, Kieran J. Phelan, MD, MSc, Joseph J. Zorc, MD,
MSCE, FAAP, Danette Stanko-Lopp, MA, MPH, Mark A.
Brown, MD, Ian Nathanson, MD, FAAP, Elizabeth
Rosenblum, MD, Stephen Sayles III, MD, FACEP, and Sinsi
Hernandez-Cancio, JD
KEY WORDS
bronchiolitis, infants, children, respiratory syncytial virus,
evidence-based, guideline
ABBREVIATIONS
AAP—American Academy of Pediatrics
AOM—acute otitis media
CI—confidence interval
ED—emergency department
KAS—Key Action Statement
LOS—length of stay
MD—mean d ...
Parent’s opinions on the diagnosis of children under 2 years of age with urin...Josep Vidal-Alaball
Urinarytractinfection(UTI)inchildhoodcanbediagnosedin5%offebrileinfants. Renal scarring is associated with increasing numbers of UTI episodes, and the incidence of renal scarring rises with each urinary infection. High levels of awareness of childhood UTI are im- portant among both professionals and parents. Whilst problems for professionals in making the diagnosis have been explored, few data exist concerning parental understanding and perspectives
Telehealth Psychology Building Trust with Clients.pptxThe Harvest Clinic
Telehealth psychology is a digital approach that offers psychological services and mental health care to clients remotely, using technologies like video conferencing, phone calls, text messaging, and mobile apps for communication.
The Importance of Community Nursing Care.pdfAD Healthcare
NDIS and Community 24/7 Nursing Care is a specific type of support that may be provided under the NDIS for individuals with complex medical needs who require ongoing nursing care in a community setting, such as their home or a supported accommodation facility.
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdfSachin Sharma
This content provides an overview of preventive pediatrics. It defines preventive pediatrics as preventing disease and promoting children's physical, mental, and social well-being to achieve positive health. It discusses antenatal, postnatal, and social preventive pediatrics. It also covers various child health programs like immunization, breastfeeding, ICDS, and the roles of organizations like WHO, UNICEF, and nurses in preventive pediatrics.
Antibiotic Stewardship by Anushri Srivastava.pptxAnushriSrivastav
Stewardship is the act of taking good care of something.
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
WHO launched the Global Antimicrobial Resistance and Use Surveillance System (GLASS) in 2015 to fill knowledge gaps and inform strategies at all levels.
ACCORDING TO apic.org,
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
ACCORDING TO pewtrusts.org,
Antibiotic stewardship refers to efforts in doctors’ offices, hospitals, long term care facilities, and other health care settings to ensure that antibiotics are used only when necessary and appropriate
According to WHO,
Antimicrobial stewardship is a systematic approach to educate and support health care professionals to follow evidence-based guidelines for prescribing and administering antimicrobials
In 1996, John McGowan and Dale Gerding first applied the term antimicrobial stewardship, where they suggested a causal association between antimicrobial agent use and resistance. They also focused on the urgency of large-scale controlled trials of antimicrobial-use regulation employing sophisticated epidemiologic methods, molecular typing, and precise resistance mechanism analysis.
Antimicrobial Stewardship(AMS) refers to the optimal selection, dosing, and duration of antimicrobial treatment resulting in the best clinical outcome with minimal side effects to the patients and minimal impact on subsequent resistance.
According to the 2019 report, in the US, more than 2.8 million antibiotic-resistant infections occur each year, and more than 35000 people die. In addition to this, it also mentioned that 223,900 cases of Clostridoides difficile occurred in 2017, of which 12800 people died. The report did not include viruses or parasites
VISION
Being proactive
Supporting optimal animal and human health
Exploring ways to reduce overall use of antimicrobials
Using the drugs that prevent and treat disease by killing microscopic organisms in a responsible way
GOAL
to prevent the generation and spread of antimicrobial resistance (AMR). Doing so will preserve the effectiveness of these drugs in animals and humans for years to come.
being to preserve human and animal health and the effectiveness of antimicrobial medications.
to implement a multidisciplinary approach in assembling a stewardship team to include an infectious disease physician, a clinical pharmacist with infectious diseases training, infection preventionist, and a close collaboration with the staff in the clinical microbiology laboratory
to prevent antimicrobial overuse, misuse and abuse.
to minimize the developme
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
Medical Technology Tackles New Health Care Demand - Research Report - March 2...pchutichetpong
M Capital Group (“MCG”) predicts that with, against, despite, and even without the global pandemic, the medical technology (MedTech) industry shows signs of continuous healthy growth, driven by smaller, faster, and cheaper devices, growing demand for home-based applications, technological innovation, strategic acquisitions, investments, and SPAC listings. MCG predicts that this should reflects itself in annual growth of over 6%, well beyond 2028.
According to Chris Mouchabhani, Managing Partner at M Capital Group, “Despite all economic scenarios that one may consider, beyond overall economic shocks, medical technology should remain one of the most promising and robust sectors over the short to medium term and well beyond 2028.”
There is a movement towards home-based care for the elderly, next generation scanning and MRI devices, wearable technology, artificial intelligence incorporation, and online connectivity. Experts also see a focus on predictive, preventive, personalized, participatory, and precision medicine, with rising levels of integration of home care and technological innovation.
The average cost of treatment has been rising across the board, creating additional financial burdens to governments, healthcare providers and insurance companies. According to MCG, cost-per-inpatient-stay in the United States alone rose on average annually by over 13% between 2014 to 2021, leading MedTech to focus research efforts on optimized medical equipment at lower price points, whilst emphasizing portability and ease of use. Namely, 46% of the 1,008 medical technology companies in the 2021 MedTech Innovator (“MTI”) database are focusing on prevention, wellness, detection, or diagnosis, signaling a clear push for preventive care to also tackle costs.
In addition, there has also been a lasting impact on consumer and medical demand for home care, supported by the pandemic. Lockdowns, closure of care facilities, and healthcare systems subjected to capacity pressure, accelerated demand away from traditional inpatient care. Now, outpatient care solutions are driving industry production, with nearly 70% of recent diagnostics start-up companies producing products in areas such as ambulatory clinics, at-home care, and self-administered diagnostics.
Health Education on prevention of hypertensionRadhika kulvi
Hypertension is a chronic condition of concern due to its role in the causation of coronary heart diseases. Hypertension is a worldwide epidemic and important risk factor for coronary artery disease, stroke and renal diseases. Blood pressure is the force exerted by the blood against the walls of the blood vessels and is sufficient to maintain tissue perfusion during activity and rest. Hypertension is sustained elevation of BP. In adults, HTN exists when systolic blood pressure is equal to or greater than 140mmHg or diastolic BP is equal to or greater than 90mmHg. The